Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Nutex (NUTX) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Nutex between August 8, 2024 and August 14, 2025and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar ...

NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- WHY: New York, N.Y., October 6, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), of the important October 21, 2025 lead plaintiff deadline. SO WHAT: If you purchased Nutex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a ...

SAN DIEGO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP announces that a class action lawsuit has commenced on behalf of investors of Nutex Health Inc. (NASDAQ: NUTX) (“Nutex” or the “Company”). The lawsuit seeks to recover losses on behalf of investors who purchased the Company’s securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Period”). If you purchased Nutex securities and suffered losses, you have until October 21, 2025, to seek appointment as lead plaintiff. Inves ...

Accessibility StatementSkip Navigation DEADLINE: October 21, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/nutex-health-inc-loss-submission-form/? id=169609&from=4 NEW YORK, Sept. 29, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX). NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of NUTX during the t ...

Accessibility StatementSkip Navigation NEW YORK, Sept. 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX). Shareholders who purchased shares of NUTX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/nutex-health-inc-loss-submission-form/?id=1 ...

Core Viewpoint - Nutex Health Inc. is facing a class action securities lawsuit due to alleged securities fraud that occurred between August 8, 2024, and August 14, 2025, impacting investors adversely [1][2]. Group 1: Allegations and Impact - The lawsuit claims that Nutex Health Inc. made false statements and concealed information regarding its third-party vendor HaloMD, which allegedly engaged in fraudulent activities to defraud insurance companies [2]. - It is alleged that revenues from Nutex's engagement with HaloMD were unsustainable due to the fraudulent conduct, leading to overstated business and financial prospects [2]. - The company reportedly overstated its remediation of material weaknesses in internal controls over financial reporting, affecting its ability to account for stock-based compensation obligations correctly [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until October 21, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, indicating a no-cost participation model [3]. Group 3: Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years and ranking among the top securities litigation firms in the U.S. [4].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Nutex Health Inc. due to allegations of violations of federal securities laws, with a deadline for investors to seek lead plaintiff status in a class action lawsuit set for October 21, 2025 [3][5]. Group 1: Allegations Against Nutex - The complaint alleges that Nutex and its executives made false and misleading statements, failing to disclose a coordinated scheme to defraud insurance companies through HaloMD [5]. - It is claimed that revenues from HaloMD's engagement were unsustainable due to fraudulent conduct, and Nutex overstated its ability to remediate weaknesses in its internal controls over financial reporting [5]. - Nutex is accused of improperly calculating stock-based compensation obligations, which increased the risk of failing to file timely financial reports with the SEC [5]. Group 2: Market Reaction - Following the release of a short report by Blue Orca Capital, Nutex's stock price fell by $11.18 per share, or 10.05%, closing at $100.01 on July 22, 2025 [6][7]. - After Nutex announced a delay in filing its Form 10-Q due to accounting adjustments, its stock price dropped further by $18.22 per share, or 16.39%, closing at $92.91 on August 15, 2025 [8]. Group 3: Legal Proceedings - The lead plaintiff in the class action will be the investor with the largest financial interest who is typical of class members, and any member can move to serve as lead plaintiff [9]. - Faruqi & Faruqi encourages individuals with information regarding Nutex's conduct to come forward, including whistleblowers and former employees [10].

Core Viewpoint - Nutex Health Inc. is facing allegations of issuing materially false and misleading statements during the class period from August 8, 2024, to August 14, 2025, related to its financial reporting and business practices [1]. Group 1: Allegations Against Nutex Health Inc. - The complaint alleges that Nutex's third-party vendor, HaloMD, engaged in fraudulent activities to defraud insurance companies, leading to unsustainable revenue [1]. - Nutex is accused of overstating its remediation efforts regarding material weaknesses in its internal controls over financial reporting [1]. - The company improperly classified stock-based compensation obligations as equity instead of liabilities, increasing the risk of delayed financial report filings with the SEC [1]. Group 2: Class Action Details - Shareholders who purchased shares of Nutex during the specified class period are encouraged to register for the class action, with a deadline of October 21, 2025, to seek lead plaintiff status [2]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the lifecycle of the case [2]. - Participation in the case incurs no cost or obligation for shareholders [2]. Group 3: Law Firm's Commitment - The Gross Law Firm aims to protect investors' rights against deceit and fraud, ensuring companies adhere to responsible business practices [3]. - The firm seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated stock prices [3].

Core Viewpoint - A class action lawsuit has been filed against Nutex Health Inc. for violations of federal securities laws, impacting investors who acquired Nutex securities during the specified Class Period from August 8, 2024, to August 14, 2025 [1][2]. Group 1: Allegations Against Nutex - The lawsuit alleges that Nutex and its officers made false and misleading statements regarding the company's financial practices and internal controls [2]. - Specific claims include that Nutex engaged in fraudulent activities through HaloMD, leading to unsustainable revenue and improper accounting of stock-based compensation obligations [2]. - The company is accused of overstating its financial prospects and failing to disclose material weaknesses in its internal controls over financial reporting [2]. Group 2: Impact on Investors - Following the revelation of these allegations, Nutex's common stock experienced a significant decline, resulting in financial losses for investors [3]. - Investors who suffered losses exceeding $50,000 are encouraged to participate in the lawsuit, with a deadline to act as Lead Plaintiff set for October 21, 2025 [3]. Group 3: About the Law Firm - Lowey Dannenberg P.C. is a law firm specializing in representing institutional and individual investors who have suffered financial losses due to corporate fraud and violations of federal securities laws [4]. - The firm has a track record of prosecuting multi-million-dollar lawsuits and has recovered billions for its clients [4].

Core Viewpoint - Investors in Nutex Health Inc. have the opportunity to lead a securities fraud class action lawsuit due to alleged undisclosed fraudulent activities and financial misstatements by the company [1][2]. Summary by Relevant Sections Lawsuit Details - The lawsuit alleges that from August 8, 2024, to August 14, 2025, Nutex Health Inc. failed to disclose that HaloMD was involved in a scheme to defraud insurance companies, leading to unsustainable revenue [2]. - The company is accused of overstating its remediation of material weaknesses in internal controls over financial reporting, which affected its ability to account for stock-based compensation obligations [2]. - Nutex allegedly misclassified stock-based compensation obligations as equity instead of liabilities, increasing the risk of delayed financial report filings with the SEC [2]. - Positive statements made by the company regarding its business and financial prospects were claimed to be materially misleading and lacked a reasonable basis [2].